Clinical Trial Update: Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating four dosing regimens of OTL78 injection in prostate cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• OTL78 injection (OTL78)

Snippet

Sponsor: Clinton Bahler | Conditions: Prostate Cancer Surgery, Prostate Cancer Metastatic Disease | Phase 2 | Status: RECRUITING